Prothena Corporation PLC PRTA:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/20/21 EDT
74.81quote price arrow down-2.26 (-2.93%)
Volume
273,466
52 week range
9.67 - 78.40
Loading...
  • Open75.21
  • Day High77.32
  • Day Low73.61
  • Prev Close74.81
  • 52 Week High78.40
  • 52 Week High Date09/10/21
  • 52 Week Low9.67
  • 52 Week Low Date09/29/20

Key Stats

  • Market Cap3.37B
  • Shares Out45.05M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change522.9

KEY STATS

  • Open75.21
  • Day High77.32
  • Day Low73.61
  • Prev Close74.81
  • 52 Week High78.40
  • 52 Week High Date09/10/21
  • 52 Week Low9.67
  • 52 Week Low Date09/29/20
  • Market Cap3.37B
  • Shares Out45.05M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change522.9

RATIOS/PROFITABILITY

  • EPS (TTM)-1.86
  • P/E (TTM)-40.11
  • Fwd P/E (NTM)144.14
  • EBITDA (MRQ)-63.97M
  • ROE (MRQ)-26.93%
  • Revenue (MRQ)60.75M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-115.87%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Prothena Corporation PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Prothena Corporation PLC is an Ireland-based late-stage clinical company. The Company provides solutions for protein dysregulation and a pipeline of investigational therapeutics to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. It operates pipeline of therapeutic candidates to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. The Company focuses on the development of...
Lars Ekman M.D., Ph.D.
Non-Executive Chairman
Gene Kinney Ph.D.
President
Tran Nguyen
Chief Financial Officer
Karin Walker CPA
Chief Accounting Officer
Address
77 Sir John Rogersons Quay
Block C, Grand Canal Docklands
Dublin
D02 T804
Ireland

Top Peers

SYMBOLLASTCHG%CHG
PRNB
RLAY
Relay Therapeutics Inc
36.22-0.87-2.35%
ALLO
Allogene Therapeutics Inc
24.88-0.50-1.97%
TPTX
Turning Point Therapeutics Inc
78.89+0.83+1.06%
SWTX
SpringWorks Therapeutics Inc
71.25-3.55-4.75%